← Leaderboards
Lianchun Wang
University Of Georgia
$10,893,566
Attributed
$15,890,483
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,890,483 · 18
By mechanism
R01$7,322,999 · 5
RF1$4,388,901 · 2
U01$2,588,098 · 1
R56$785,263 · 1
R21$582,000 · 1
P41$223,222 · 8
Top collaborators
- Houjian Cai6 shared
- Jian None Liu4 shared
- Chunyu Wang4 shared
- Robert J Linhardt2 shared
- Ramani Ramchandran1 shared
Most similar at University Of Georgia
Same institution · by research overlap
- Houjian Cai$3,852,418
- Ryan Joseph Weiss$2,040,003
Others in their field
Top investigators on “Heparitin Sulfate”
- Jeffrey D Esko · University Of California San Diego$17,527,370
- Pyong Woo Park · Baylor College Of Medicine$14,878,527
- Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute$12,341,999
- Vincent C. Hascall · Cleveland Clinic Foundation$11,439,932
- Jian None Liu · University Of North Carolina Chapel Hill$9,367,049
- Umesh Ramanlal Desai · Versiti Blood Health, Inc.$7,283,130
Research focus
Heparitin SulfateCell SurfaceMolecularIn VivoSignal TransductionCellsIn VitroMediatingProteinsAlzheimer&AposReceptorGenesCell PhysiologyEndothelial CellsBiochemicalNovel TherapeuticsGeneticBasePolysaccharidesHeparan Sulfate ProteoglycanMouse ModelKnock-OutMalignant NeoplasmsCell Motility
Grant awards (36)
ApoE and Heparan Sulfate Interaction in Alzheimerâs Disease$732,702
R01 · FY2025 · AG
Basolateral brain endothelial cilia and its role in promoting vascular stability$661,170
R01 · FY2025 · HL
Heparan sulfate proteoglycan in the brain vascular clearance of amyloid-β and Alzheimer's disease$587,928
R01 · FY2025 · AG · contact PI
ApoE and Heparan Sulfate Interaction in Alzheimerâs Disease$782,087
R01 · FY2024 · AG
Heparan sulfate proteoglycan in the brain vascular clearance of amyloid-β and Alzheimer's disease$599,927
R01 · FY2024 · AG · contact PI
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease$554,778
R01 · FY2024 · AG
Heparan Sulfate in Prostate Cancer$374,688
U01 · FY2023 · CA · contact PI
Heparan Sulfate in Prostate Cancer$509,930
U01 · FY2022 · CA · contact PI
Heparan sulfate proteoglycan in the brain vascular clearance of amyloid-β and Alzheimer's disease$1,793,781
RF1 · FY2021 · AG · contact PI
Heparan Sulfate in Prostate Cancer$1
U01 · FY2021 · CA · contact PI
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease$2,595,120
RF1 · FY2020 · AG
Heparan Sulfate in Prostate Cancer$539,856
U01 · FY2020 · CA · contact PI
Heparan Sulfate in Prostate Cancer$561,653
U01 · FY2019 · CA · contact PI
Heparan sulfate proteoglycan in Alzheimer's disease$785,263
R56 · FY2018 · AG · contact PI
Heparan Sulfate in Prostate Cancer$601,970
U01 · FY2018 · CA · contact PI
Robo4 and heparan sulfate proteoglycan in angiogenesis$371,028
R01 · FY2018 · HL · contact PI
Robo4 and heparan sulfate proteoglycan in angiogenesis$3,972
R01 · FY2018 · HL · contact PI
Robo4 and heparan sulfate proteoglycan in angiogenesis$375,000
R01 · FY2017 · HL · contact PI
Robo4 and heparan sulfate proteoglycan in angiogenesis$411,273
R01 · FY2016 · HL · contact PI
Using CRISPR-Cas9 technology to develop a mutant cell library for heparan sulfate structure-function study$291,000
R21 · FY2016 · HL · contact PI
Robo4 and heparan sulfate proteoglycan in angiogenesis$374,375
R01 · FY2015 · HL · contact PI
Using CRISPR-Cas9 technology to develop a mutant cell library for heparan sulfate structure-function study$291,000
R21 · FY2015 · HL · contact PI
Robo4 and heparan sulfate proteoglycan in angiogenesis$37,575
R01 · FY2015 · HL · contact PI
Heparan sulfate proteoglycan interacts with Slit/Robo to regulate angiogenesis$349,896
R01 · FY2013 · HL · contact PI
Heparan sulfate proteoglycan interacts with Slit/Robo to regulate angiogenesis$367,538
R01 · FY2012 · HL · contact PI
Heparan sulfate proteoglycan interacts with Slit/Robo to regulate angiogenesis$371,250
R01 · FY2011 · HL · contact PI
GENERATION OF HEPARAN SULFATE MUTANT MOUSE ENDOTHELIAL CELL LINES$106,295
P41 · FY2011 · RR · contact PI
NEW STRATEGIES TO DETERMINE STRUCTURE-FUNCTION RELATIONSHIPS OF HS CO-RECEPTORS$106,295
P41 · FY2011 · RR · contact PI
REGULATORY ROLE OF HEPARAN SULFATE ON SLIT3/ROBO-MEDIATED ANGIOGENESIS$1,772
P41 · FY2011 · RR · contact PI
MOLECULAR MECHANISMS UNDERLYING HEPARIN-INDUCED LEUKOCYTOSIS$1,772
P41 · FY2011 · RR · contact PI
ROLE OF ENDOTHELIUM ON MYOCARDIAL INFARCTION INJURY RESPONSE$1,772
P41 · FY2011 · RR · contact PI
REGULATORY MECHANISM OF HEPARIN/HEPARAN SULFATE ON VEGF SIGNALING$1,772
P41 · FY2011 · RR · contact PI
CHARACTERIZATION OF GLYCOSAMINOGLYCANS BY 15N NMR & IN VIVO ISOTOPIC LABELING$1,772
P41 · FY2011 · RR · contact PI
REGULATORY ROLE OF HEPARAN SULFATE EMBRYONIC STEM CELL BIOLOGY$1,772
P41 · FY2011 · RR · contact PI
Heparan sulfate proteoglycan interacts with Slit/Robo to regulate angiogenesis$371,250
R01 · FY2010 · HL · contact PI
Heparan sulfate proteoglycan interacts with Slit/Robo to regulate angiogenesis$371,250
R01 · FY2009 · HL · contact PI